monthly glp 1 injection NEW: Medicare GLP-1 Bridge Program Beginning July 1, 2026, eligible Medicare Part D beneficiaries may have access to certain GLP-1 medications (Zepbound, Foundayo, Wegovy) for weight management for a $50 Transformative GLP-1 Weight Loss Program

Astrocytes as Key Regulators of Neural Signaling in Health and Disease

Anti-Aging Effects Growth hormone is known for its anti-aging properties (3)

- **Glutathione 500mg**

Peripheral blood samples were analyzed for concentrations of metalloproteinase (MMP)-9, tissue inhibitors of MMP (TIMP)-1,2, and myeloperoxidase (MPO)

Key Findings Diabetes-related findings: Over a 30-month period, users of GLP-1s for diabetes experienced a slower increase in medical cost growth compared to non-users

This development wont just affect drugmakers it will also have impacts on medical device manufacturers (medtech), insurance coverage, consumer behavior and overall public health